Biguanide derivatives and their rearrangement products for use in the treatment of cancer
US11440906B2 · kind B2 · utility
0Cited by
0References
5Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 21, 2018 |
| Grant date | Sep 13, 2022 |
| Priority date | — |
| Expiry date | Dec 21, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/12
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present disclosure relates to biguanide derivatives of formula (I) and their rearrangement products. The present disclosure also relates to the use of these compounds in a method for treating cancer, in particular melanoma.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.